We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

38 hedge funds and large institutions have $22.3M invested in Alpine Immune Sciences Inc in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

24% less funds holding

Funds holding: 50 → 38 (-12)

55% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 22

78% less capital invested

Capital invested by funds: $100M → $22.3M (-$77.9M)

Holders
38
Holders Change
-12
Holders Change %
-24%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
7
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PAM
Panagora Asset Management
Massachusetts
+$1.22M
2
AFM
Anson Funds Management
Texas
+$938K
3
BI
BVF Inc
California
+$771K
4
Millennium Management
Millennium Management
New York
+$200K
5
FO
FT Options
Illinois
+$174K

Top Sellers

Rank Fund Capital Flow
1
Axa
Axa
France
-$5.3M
2
Franklin Resources
Franklin Resources
California
-$3.98M
3
Jennison Associates
Jennison Associates
New York
-$2.67M
4
EAM
EverPoint Asset Management
Connecticut
-$1.79M
5
SFM
Sphera Funds Management
Israel
-$1.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIP
26
Stoneridge Investment Partners
Pennsylvania
$30K – – –
WS
27
Wedbush Securities
California
$27K +$59.8K +3,000 New
Northern Trust
28
Northern Trust
Illinois
$23K +$1.46K +73 +3%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$16K – – –
Morgan Stanley
30
Morgan Stanley
New York
$10K -$37.1K -1,863 -63%
Barclays
31
Barclays
United Kingdom
$9K – – –
Creative Planning
32
Creative Planning
Kansas
$6K +$11K +550 +458%
BA
33
BlackRock Advisors
Delaware
$4K – – –
BIM
34
BlackRock Investment Management
Delaware
$4K – – –
BJ
35
BlackRock Japan
Japan
$3K -$359 -18 -4%
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2K – – –
MA
37
MUFG Americas
New York
$1K +$1.53K +77 New
FPF
38
FNY Partners Fund
New York
$67 +$149K +7,500 New
Axa
39
Axa
France
– -$5.3M -162,962 Closed
Franklin Resources
40
Franklin Resources
California
– -$3.98M -122,500 Closed
Jennison Associates
41
Jennison Associates
New York
– -$2.67M -82,191 Closed
EAM
42
EverPoint Asset Management
Connecticut
– -$1.79M -54,934 Closed
SFM
43
Sphera Funds Management
Israel
– -$1.66M -51,175 Closed
WSA
44
Wall Street Associates
California
– -$1.39M -42,600 Closed
Fidelity Investments
45
Fidelity Investments
Massachusetts
– -$813K -25,000 Closed
ECM
46
Endurant Capital Management
California
– -$694K -21,353 Closed
Alyeska Investment Group
47
Alyeska Investment Group
Illinois
– -$571K -17,551 Closed
O
48
OrbiMed
New York
– -$480K -14,750 Closed
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
– -$256K -7,880 Closed
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
– -$161K -4,951 Closed
1
2
3

ALPN Hedge Fund Activity: Q4 2016 in Review

38 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q4 2016, worth a combined $22.3M — down 78% from $100M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ALPN and 10 opened new positions — a net loss of 12 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Panagora Asset Management, opening a new position worth an estimated $1.22M. The largest seller was Axa, exiting entirely with an estimated $5.3M sold.

  • 38 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q4 2016, down from 50 in Q3 2016.
  • Funds reported $22.3M of Alpine Immune Sciences Inc stock for Q4 2016, down 78% quarter-over-quarter.
  • 10 funds opened new Alpine Immune Sciences Inc positions in Q4 2016 and 22 closed out, a net change of -12 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q4 2016 was Panagora Asset Management, an estimated $1.22M added.
  • The largest Alpine Immune Sciences Inc seller in Q4 2016 was Axa, an estimated $5.3M sold.

Based on aggregated 13F filings for Q4 2016.